|
WO2019080882A1
|
|
Hdac inhibitor and preparation method therefor and use thereof
|
|
CN109705015A
|
|
Histon deacetylase (HDAC) inhibitor and preparation method thereof and purposes
|
|
CN109705057A
|
|
Histon deacetylase (HDAC) inhibitor and preparation method thereof and purposes
|
|
CN109134433A
|
|
It is a kind of inhibit ROCK compound and its application
|
|
WO2018228452A1
|
|
Rock-inhibiting compound and uses thereof
|
|
WO2018108156A1
|
|
Rock inhibitor and application thereof
|
|
KR20180086258A
|
|
Sulfonamide derivatives and their preparation and application
|
|
WO2017114275A1
|
|
Compound for inhibiting rock, preparation method and use of same
|
|
WO2016107541A1
|
|
Pyrrole amide compound, preparation method therefor, and use thereof
|
|
WO2016107544A1
|
|
Intermediate compound for preparing pyrrole amide compound and preparation method and use thereof
|
|
WO2016107542A1
|
|
Pyrrole amide compound, preparation method therefor, and use thereof
|
|
EP3241823A1
|
|
Pyrrole amide compound, preparation method therefor, and use thereof
|
|
CN105111265A
|
|
Method for marking and modifying biomacromolecules by one-pot process
|
|
WO2014187315A1
|
|
Compound administration precursor and medicament carrier preparation
|
|
WO2014187313A1
|
|
Method for cell membrane permeation for compound
|
|
WO2014187314A1
|
|
Drug target capturing method
|
|
CN104003992A
|
|
Compounds inhibiting DPP-IV and intermediates thereof
|
|
WO2014127747A1
|
|
Dpp-iv-inhibiting compounds and intermediates thereof
|
|
CN103882532A
|
|
Synthesis and screening method and kit for lead compound
|
|
CN103882531A
|
|
Method and kit for synthesizing and screening lead compound
|
